Home > Cardiology > ACC/WCC 2020 > ACC.20/WCC Highlights Podcast Part 1 of 3

ACC.20/WCC Highlights Podcast Part 1 of 3

Presented By
Dr Rachel Giles, Medicom

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 175
Conference
ACC 2020
Trial
VICTORIA trial, VOYAGER-PAD trial, TAILOR-PCI trial, PARTNER 3 trial, CARAVAGGIO trial
Order of abstracts:

  1. Armstrong et al - VICTORIA trial - Vericiguat shows beneficial effects in very high-risk HF population

  2. Bonaca et al - VOYAGER-PAD trial - Rivaroxaban and aspirin effective and safe for PAD patients

  3. Pereira et al - TAILOR-PCI trial - TAILOR-PCI misses endpoint but still provides valuable insights

  4. Leon et al - PARTNER 3 trial - 2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis

  5. Agnelli et al - CARAVAGGIO trial - Apixaban offers new perspective for cancer patients in need of anticoagulation

  6. Samama et al - Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery





Posted on